1717 K Street NW, Suite 900

Washington, DC 20006-5349

(877) 363-6376

HELPLINE

NEWS

MesoTV: Chemotherapy + immunotherapy, another positive step in mesothelioma treatment

Drs. Anne Tsao of MD Anderson Cancer Center, Patrick Forde of Johns Hopkins, and James Stevenson of the Cleveland Clinic join Mary Hesdorffer to discuss a new clinical trial, Dream3r, a phase 3 study into the efficacy of combination chemotherapy with immunotherapy as first line treatment for mesothelioma.

Our sponsors

MesoTV is a program by the Mesothelioma Applied Research Foundation. This program is made possible by our generous sponsors: Maune Raichle Hartley French & Mudd, LLC (MRHFM)Belluck & FoxBristol Myers SquibbNovocureMerckThe Gori Law FirmEarly Lucarelli Sweeney & Meisenkothen.

Also...

In Other News

Clinical Trials

Mesothelioma is one of the rarest cancers so there are always clinical trials going on to advance research efforts. This session presents on four different

Read More »

Peritoneal Surgery/HIPEC

Peritoneal mesothelioma patients have a few different treatment options available. This session discusses two options: surgery as well as hyperthermic intraperitoneal chemotherapy (HIPEC).  This session

Read More »

Share:

Facebook
Twitter
LinkedIn